You are here: Home » PTI Stories » National » News
Business Standard

4 healthcare firms sign MoU with Odisha govt

Press Trust of India  |  Bhubaneswar 

The today signed four MoUs with different organisations for better delivery of healthcare service in the state.

The MoUs were signed with Glocal Healthcare System Private Limited, Kolkata, Centre for Stem Cell Research, Christian Medical College, Vellore, Narayan Hrudayalaya and L V Prasad Eye Institute, Bhubaneswar.


"The MoUs with institutions of national repute for delivery of quality healthcare service to people will be helpful for the state," Chief Minister Naveen patnaik, who attended the MoU signing ceremony here, said.

The Kolkota-based Glocal Health Care System Private Limited along with the state will implement the dispensary project in 14 locations of tribal dominated Nawarangpur district in the first phase. It will be extended to another 11 locations of Nawarangpur district based on the outcome of the first phase.

The dispensary centres will function as an OPD with virtual consultation with doctors through video and facility for basic laboratory test and medication dispensing, to deliver quality primary healthcare free of cost to the patients. The state has made an allocation of Rs 4 crore per annum for the project, official sources said.

The second MoU was signed with Centre for Stem Cell Research, Christian Medical College, Vellore for better detection and treatment of Thalassemia, Sickle Cell and Anemia. This will help reduce major Haemoglobinopathy disorder through screening, counselling, pre-natal diagnosis with appropriate technology and possible curative options.

In order to provide faster and better access to children detected with different heart disease, the entered into an MoU with Narayan Hrudayalaya. Under this, children suffering from congenital heart disease and rheumatic heart disease can receive required surgery through Naraya Hrudayalaya.

The city-based L V Prasad Eye Institute will provide specialised care to the needy children for treatment of congenital cataract and retinopathy of prematurity.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, December 05 2017. 19:55 IST
RECOMMENDED FOR YOU